Literature DB >> 9203456

Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.

A I Adler1, E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D G Smith.   

Abstract

OBJECTIVE: To identify risk factors for diabetic lower-extremity peripheral sensory neuropathy prospectively in a cohort of U.S. veterans with diabetes. RESEARCH DESIGN AND METHODS: General medicine clinic outpatients with diabetes were followed prospectively for the development of insensitivity to the 5.07 monofilament on the foot.
RESULTS: Of 775 subjects, 388 (50%) had neuropathy at baseline. Of the 387 subjects without neuropathy at baseline, 288 were followed up, and of these, 58 (20%) developed neuropathy. Multivariate logistic regression modeling of prevalent neuropathy controlling for sex and race revealed independent and significant associations with age, duration of diabetes, glycohemoglobin level, height, history of lower-extremity ulceration, callus, and edema; an independent and inverse correlation was noted with ankle-arm index. Risk factors for incident neuropathy in multivariate logistic regression included age, baseline glycohemoglobin level, height, history of ulcer, and CAGE screening instrument alcohol score; current smoking and albumin level were inversely associated with risk.
CONCLUSIONS: Poorer glycemic control increases the risk of neuropathy and is amenable to intervention. Height and age directly increase risk of neuropathy and may help identify patients at risk. A proportion of neuropathy in diabetic veterans is probably due to or worsened by alcohol ingestion. Neuropathy was less common in current smokers than subjects not currently smoking.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203456     DOI: 10.2337/diacare.20.7.1162

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  71 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Effects of light fingertip touch on postural responses in subjects with diabetic neuropathy.

Authors:  R Dickstein; R J Peterka; F B Horak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

3.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 4.  Risk factors for diabetic neuropathy and foot ulceration.

Authors:  A Adler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 5.  The prevalence of diabetic neuropathy according to ethnicity.

Authors:  Jay M Sosenko
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

6.  Diabetes, peripheral neuropathy, and lower-extremity function.

Authors:  Nancy S Chiles; Caroline L Phillips; Stefano Volpato; Stefania Bandinelli; Luigi Ferrucci; Jack M Guralnik; Kushang V Patel
Journal:  J Diabetes Complications       Date:  2013-10-11       Impact factor: 2.852

Review 7.  Epidemiology of diabetes and diabetes-related complications.

Authors:  Anjali D Deshpande; Marcie Harris-Hayes; Mario Schootman
Journal:  Phys Ther       Date:  2008-09-18

8.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

9.  Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.

Authors:  Claudia R L Cardoso; Camila B M Moran; Fernanda S Marinho; Marcel T Ferreira; Gil F Salles
Journal:  Diabetologia       Date:  2015-06-05       Impact factor: 10.122

Review 10.  Omega-3 and omega-6 fatty acids and type 2 diabetes.

Authors:  Charlotte Jeppesen; Katja Schiller; Matthias B Schulze
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.